1 Nitric oxide (NO) is continuously produced in the lung and is present in
exhaled air. We examined the effect of beta-adrenoceptor stimulation on the
production of pulmonary NO in rabbits.
2 Exhaled NO was measured by chemiluminescence in anaesthetized and mechani
cally ventilated rabbits and in buffer-perfused rabbit lungs.
3 Intravenous infusions of adrenaline (0.1-10 mu g kg(-1) min(-1)) elicited
dose-dependent increases in exhaled NO. The increases in exhaled NO compri
sed an initial peak followed by a lower plateau level. The increase in exha
led NO was inhibited by propranolol (1 mg kg(-1)) but not by phentolamine (
1 mg kg(-1)).
4 Prenalterol, a beta(1)-adrenoceptor agonist, and terbutaline, a beta(2)-a
drenoceptor agonist, also caused dose-dependent increases in exhaled NO. Ho
wever, prenalterol was >100 times more potent than terbutaline.
5 Infusions of forskolin (0.01-0.03 mu mol kg(-1) min(-1)), an adenylate cy
clase stimulator, elicited dose-dependent decreases in blood pressure and c
oncomitant increases in heart rate but caused no alterations in exhaled NO.
6 Nimodipine, a L-type calcium channel blocker, antagonized the increases i
n exhaled NO in response to prenalterol infusions.
7 The increases in exhaled NO in response to adrenaline and prenalterol wer
e also present in blood-free, buffer perfused lungs during constant-flow co
nditions.
8 These results demonstrate that pulmonary nitric oxide production can be e
nhanced by beta-adrenoceptor stimulation. Furthermore, the results indicate
that the beta-adrenergic stimulation of pulmonary NO production is not cri
tically dependent on cyclic AMP formation but may require intact calcium-ch
annels.